12/17/2024
4:21 PM | Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:22 PM | Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:23 PM | ORIC Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
8:31 PM | Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
8:34 PM | Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
8:29 PM | ORIC Pharmaceuticals (Subject)
Piscitelli Dominic (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:54 PM | EcoR1 Capital, LLC (Filed by)
ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
11/14/2024
4:47 PM | Nextech Crossover I GP S.a r.l. (Filed by)
ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
8:42 AM | ALKEON CAPITAL MANAGEMENT LLC (Filed by)
ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
| Form SC 13G | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
| Form SC 13G | |
08/12/2024
3:20 PM | ORIC Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
3:10 PM | ORIC Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:26 PM | ORIC Pharmaceuticals (Issuer)
You Angie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:21 PM | Heyman Richard A. (Reporting)
ORIC Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:22 PM | Dier Mardi (Reporting)
ORIC Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:24 PM | Hoerter Steven L. (Reporting)
ORIC Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:48 PM | Kunkel Lori Anne (Reporting)
ORIC Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
3:15 PM | ORIC Pharmaceuticals (Filer)
| Form ARS | |
04/24/2024
3:06 PM | ORIC Pharmaceuticals (Filer)
| Form DEF 14A | |
04/24/2024
3:10 PM | ORIC Pharmaceuticals (Filer)
| Form DEFA14A | |
03/29/2024
3:47 PM | ORIC Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2024
3:15 PM | ORIC Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
4:28 PM | ORIC Pharmaceuticals (Filer)
| Form S-3ASR | |
03/11/2024
3:20 PM | ORIC Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2024
7:19 AM | FMR LLC (Filed by)
ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
03/08/2024
3:20 PM | Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:19 PM | EcoR1 Capital, LLC (Filed by)
ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
5:43 PM | ALKEON CAPITAL MANAGEMENT LLC (Filed by)
ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
8:26 AM | ORIC Pharmaceuticals (Subject)
Prosight Management, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
7:01 PM | Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
4:09 PM | BlackRock Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/04/2024
11:15 PM | ORIC Pharmaceuticals (Filer)
| Form EFFECT | |
01/30/2024
11:12 AM | ORIC Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
ORIC Pharmaceuticals (Subject)
| Form SC 13G | |
01/22/2024
8:01 AM | ORIC Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
8:00 AM | ORIC Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
11:15 PM | ORIC Pharmaceuticals (Filer)
| Form EFFECT | |
